Pharmacological p38 MAPK inhibitor SB203580 enhances AML stem cell line KG1a chemosensitivity to daunorubicin by promoting late apoptosis, cell growth arrest in S-phase, and miR-328-3p upregulationSara Bahattab, Sabine Matou‐Nasri|Saudi Pharmaceutical Journal|2024Cited by 3